A concerning new study reveals a significant link between hallucinogen use requiring hospital care and an increased risk of developing mania. This research, published in PLOS Medicine, highlights a critical area of concern, especially with the growing interest in these substances.
The study, led by Daniel Myran from North York General Hospital in Canada, found that individuals who sought emergency or hospital care due to hallucinogen use faced a six-fold higher risk of requiring subsequent care for mania within the next three years. This is a substantial increase, underscoring the potential dangers associated with these substances.
Hallucinogens like ketamine, LSD (lysergic acid diethylamide), and psilocybin are gaining traction, both recreationally and in medical settings for treating conditions like depression and post-traumatic stress disorder. But here's where it gets controversial: despite their potential therapeutic benefits, these drugs may trigger mania or the onset of bipolar disorder (BD) in susceptible individuals.
To investigate this association, researchers analyzed data from hospitalizations and emergency department (ED) visits between January 2008 and December 2022. They compared groups of patients who used hallucinogens, those hospitalized for other reasons, and the general population. The aim was to assess the likelihood of needing ED visits or hospitalization for mania, or receiving a diagnosis of BD within three years.
The results are striking. By comparing records of 7,285 patients who received acute care for hallucinogen use to 78,201 patients hospitalized for other causes, the study found that those with hallucinogen-related ED visits or hospitalizations were six times more likely to seek treatment for mania and four times more likely to be diagnosed with BD compared to the control group. The risk was comparable to those with ED or hospital care for cannabis use, which has also been linked to an increased risk of mania.
Interestingly, the study revealed that two-thirds of those receiving care for hallucinogens had prior substance use visits, and nearly half had previous mental health care visits.
The study's authors emphasize that the findings are limited to individuals who required urgent medical care, and may not apply to the majority of people who use hallucinogens without needing such care. However, they suggest that using hallucinogens that result in the need for urgent health care may increase the risk of later developing mania or BD. The authors state that the findings may be due to ED or hospital care involving hallucinogen use occurring in individuals at greater risk for mania or BD rather than a direct risk of hallucinogens.
“Our study showed a strong association between hallucinogen use that requires care in the emergency room or hospital and future risk of mania and bipolar disorder,” says Daniel Myran.
But this raises a critical question: Does this mean hallucinogens directly cause mania, or do they simply exacerbate underlying vulnerabilities?
Coauthor Marco Solmi adds, “Our results fill an important gap around the complexity of therapeutic versus safety profile of hallucinogen use. Future projects will need to identify predictors of beneficial versus harmful outcomes at the individual level.”
This study serves as a crucial reminder of the potential risks associated with hallucinogens, particularly for those with pre-existing mental health vulnerabilities. It underscores the need for careful consideration and further research to understand the complex relationship between these substances and mental health outcomes.
What are your thoughts on these findings? Do you believe the risks outweigh the potential benefits of hallucinogens in medical settings? Share your opinions in the comments below!
